The spring meeting of the Irish Society for Gastroenterology highlighted research into current clinical practices – while ...

Material and method. Material and method. Data on patients registered as having C18 (colon cancer), C19–C21 (cancer of the rectum, rectosigmoid junction or anus), C33–C34 (cancer of the lungs or ...

Blood Test Could Guide Use of Anti-Inflammatory Drug Celecoxib to Reduce Risk of Colon Cancer Recurrence Jan. 28, 2025 — A data analysis from a randomized clinical trial for stage 3 colon cancer ...

It might even have anti-cancer properties. Previous research indicates that metformin could offer a protective effect against the development of colon cancer. For instance, a meta-analysis of 58 ...

Metformin is the most widely prescribed diabetes drug in the world. Scientists believe the drug has some colon-cancer prevention benefits. New research provides hints about its use as a ...

Two years ago, Emma Dimery was told her stage 4 colon cancer was incurable. Today, she is healthy and cancer-free — and she says a last-resort clinical trial saved her life. Dimery, who lives in ...

However, the finding that p53 degradation initiates the tumor process in colon cancer is completely new. This study, with Irene Herranz-Montoya as first author, has found that the shortage of p53 ...

Those with stage II (2) disease sometimes have chemotherapy. Chemotherapy is typical for people with stage III (3). If colon cancer has spread to other organs (stage IV (4)), like your liver, ...

This frees up your immune system to attack. Your care team at Fred Hutch Cancer Center may recommend immune checkpoint inhibitors if your colon cancer has certain features: dMMR (deficient mismatch ...

Modern lifestyles are thought to damage gut health in a way that raises the risk of colon cancer. Lifestyle changes can improve the gut microbiome, which could lower the risk of colon cancer.

The Phase I trial — meaning it is the first in humans and had the goal of showing the therapy is safe — examined 12 patients with gastrointestinal cancers, including colon and rectal cancer.